Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
20 hours ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, 22 hours ago
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.

Does pomegranate play role in management of biochemically recurrent prostate cancer?

06 Sep 2017

Pomegranate juice and extract are safe but do not favourably influence outcomes in prostate cancer patients with biochemical recurrence (BCR), a study has shown. However, a subset of BCR patients with the manganese superoxide dismutase (MnSOD) AA genotype appear to respond positively to the antioxidant effects of pomegranate.

With the aim of determining whether pomegranate products could slow the growth of prostate cancer, researchers conducted a review of trials involving patients on active surveillance, patients receiving neoadjuvant treatment, patients with BCR after local prostate cancer therapy, and patients with metastatic castration-resistant prostate cancer (mCRPC).

Data from early phase II trials in a BCR patient population showed that both pomegranate juice and extract significantly prolonged prostate-specific antigen (PSA) doubling time (PSADT), confirming the safety of pomegranate products.

In a placebo-controlled phase III trial, on the other hand, although pomegranate extract did not significantly lengthen PSADT in BCR patients, a preplanned subset analysis of patients with the MnSOD AA genotype demonstrated notable PSADT lengthening in the pomegranate extract arm.

Meanwhile, a large trial conducted in a neoadjuvant population found a substantial increase in urolithin A and a nonsignificant reduction in 8-hydroxy-2-deoxyguanosine, a marker of oxidation in prostate cancer tissue, in the pomegranate vs the placebo arm.

Furthermore, a randomized clinical trial of a polyphenol-rich multicomponent food supplement containing 31.25 percent pomegranate extract reported a significant slowing of PSA increase in the food supplement arm vs placebo in patients on active surveillance and those with BCR.

Preclinical studies showing that pomegranate juice and its components inhibit prostate cancer have reported that 90 percent of the antioxidant activity of the fruit is provided by the punicalagins and other hydrolysable tannins derived from pomegranate. [J Agric Food Chem 2000; 48: 4581–4589]

“Patients asking about pomegranate juice or extract consumption should be referred to the Prostate Cancer, Nutrition, and Dietary Supplements–Patient Version at the National Cancer Institute, where they will find brief summaries of the source of bioactive compounds in pomegranates, and the results of preclinical studies and clinical trials in the biochemically recurrent prostate cancer patient population, concluding with the phase III trial results showing no differences in PSADTs between placebo and pomegranate arms,” researchers said.

They added that if the beneficial effect of pomegranate products in patients with the MnSOD AA genotype is confirmed in future studies, testing for MnSOD status may be beneficial in guiding patients.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
20 hours ago
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
Tristan Manalac, 22 hours ago
Statin use, particularly in smokers, obese patients and nondiabetics, has a strong and dose-dependent association with decreasing risk of pancreatic ductal adenocarcinoma (PDAC), according to a new study.